Aminoglycoside Toxicosis
Basic Information 
Epidemiology
Clinical Presentation
Physical Exam Findings
Usually related to the original disease for which the aminoglycoside was being administered
Etiology and Pathophysiology
Nephrotoxicity is caused by accumulation of the drug in the renal tubular epithelial cells.
• Aminoglycosides enter the renal tubule after filtration through the glomerulus.
• Cationic aminoglycoside molecules bind to anionic phospholipids on the proximal tubular cells.
• The aminoglycoside is taken into the cell by carrier-mediated pinocytosis and translocated into cytoplasmic vacuoles, which fuse with lysosomes.
• With additional pinocytosis, drug continues to accumulate within the lysosomes.
• The accumulated aminoglycoside interferes with normal lysosomal function, and the overloaded lysosomes eventually swell and rupture.
• Lysosomal enzymes, phospholipids, and the aminoglycoside are released into the cytosol of the proximal tubular cell, disrupting other organelles and causing cell death.
• Neomycin is the most nephrotoxic, and streptomycin and dihydrostreptomycin are the least nephrotoxic.
• Amikacin is often recommended in critical patients over gentamicin because it is considered less nephrotoxic.
Diagnosis 
< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

